SEC Form 4 · accession 0001131096-15-000004
ATHENAHEALTH INC · ATHN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Cosinuke
Officer — SVP, Chief Marketing Officer
Period of report
Jan 5, 2015
Accepted (ET)
Jan 6, 2015 · 7:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131096
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 5, 2015 | M | 6,000 | $25.67 | A | 48,804 | D | |
| Common StockF1,F2 | Jan 5, 2015 | S | 900 | $143.00 | D | 47,904 | D | |
| Common StockF1,F3 | Jan 5, 2015 | S | 1,100 | $143.85 | D | 46,804 | D | |
| Common StockF1,F4 | Jan 5, 2015 | S | 2,800 | $145.69 | D | 44,004 | D | |
| Common StockF1,F5 | Jan 5, 2015 | S | 1,200 | $146.84 | D | 42,804 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $25.67 | Jan 5, 2015 | M | 6,000 | D | Jan 5, 2010 | Mar 2, 2019 | Common Stock | 6,000 | 18,000 | D |
Explanation of responses
- F1The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on October 21, 2014, in accordance with Rule 10b5-1
- F2This price represents the weighted average of sales ranging from $142.60 to $143.45. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F3This price represents the weighted average of sales ranging from $143.68 to $144.19. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F4This price represents the weighted average of sales ranging from $145.20 to $146.17. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F5This price represents the weighted average of sales ranging from $146.58 to $147.26. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.